Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prednisolone does not prevent post-herpetic neuralgia.

V Esmann, J P Geil, S Kroon

    Lancet (London, England)
    |July 18, 1987
    PubMed
    Summary

    This study found that prednisolone did not significantly reduce the long-term incidence of post-herpetic neuralgia in herpes zoster patients. However, it provided short-term pain relief in the initial days of treatment.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Evolution of Pulmonary Arteriovenous Malformations: The Role of Contrast Echocardiography.

    Chest·2022
    Same author

    Idiopathic and hereditary haemorrhagic telangiectasia associated pulmonary arteriovenous malformations: comparison of clinical and radiographic characteristics.

    Clinical radiology·2021
    Same author

    Oral itraconazole for epistaxis in hereditary hemorrhagic telangiectasia: a proof of concept study.

    Angiogenesis·2020
    Same author

    Intranasal Efudix reduces epistaxis in hereditary hemorrhagic telangiectasia.

    Angiogenesis·2020
    Same author

    Alemtuzumab is effective against severe chronic lymphocytic leukaemia-associated paraneoplastic pemphigus.

    The British journal of dermatology·2013
    Same author

    Fungal soil communities in a young transgenic poplar plantation form a rich reservoir for fungal root communities.

    Ecology and evolution·2012

    Area of Science:

    • Neurology
    • Immunology
    • Pharmacology

    Background:

    • Post-herpetic neuralgia (PHN) is a common complication of herpes zoster (shingles).
    • Early intervention aims to prevent the development of chronic neuropathic pain.
    • The role of corticosteroids in managing acute herpes zoster and preventing PHN is debated.

    Purpose of the Study:

    • To evaluate the efficacy of prednisolone in preventing the development of post-herpetic neuralgia.
    • To assess the impact of prednisolone on pain relief during the acute phase of herpes zoster.

    Main Methods:

    • A randomized, double-blind, placebo-controlled trial was conducted.
    • 78 patients with recent onset herpes zoster (<96 hours) received acyclovir and either prednisolone or placebo.
    • Prednisolone was administered in a tapering dose over 3 weeks.

    Related Experiment Videos

    Main Results:

    • At 6 months, 18 (23%) patients developed PHN, with no significant difference between the prednisolone (24.3%) and placebo (22.5%) groups.
    • The 95% confidence interval for the difference in PHN incidence was -17% to +20%.
    • Prednisolone demonstrated a significant short-term benefit, relieving pain for the first 3 days of treatment.

    Conclusions:

    • Prednisolone does not appear to reduce the incidence of post-herpetic neuralgia at 6 months post-herpes zoster.
    • The 1-2 week period after acute zoster onset is critical for neuralgia establishment.
    • While not preventing long-term PHN, prednisolone offers temporary pain relief in the acute phase.